VCG
Vantage Consulting Group’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,305
| Closed | -$246K | – | 207 |
|
|
2024
Q1 | $246K | Sell |
2,305
-607
| -21% | -$64.7K | 0.16% | 125 |
|
|
2023
Q4 | $290K | Buy |
2,912
+757
| +35% | +$75.3K | 0.19% | 94 |
|
|
2023
Q3 | $223K | Buy |
2,155
+287
| +15% | +$29.6K | 0.15% | 155 |
|
|
2023
Q2 | $227K | Buy |
1,868
+135
| +8% | +$16.4K | 0.13% | 173 |
|
|
2023
Q1 | $266K | Buy |
1,733
+382
| +28% | +$58.7K | 0.15% | 115 |
|
|
2022
Q4 | $243K | Sell |
1,351
-460
| -25% | -$82.6K | 0.14% | 142 |
|
|
2022
Q3 | $214K | Sell |
1,811
-78
| -4% | -$9.22K | 0.13% | 171 |
|
|
2022
Q2 | $270K | Buy |
1,889
+227
| +14% | +$32.4K | 0.15% | 97 |
|
|
2022
Q1 | $286K | Buy |
1,662
+648
| +64% | +$112K | 0.11% | 97 |
|
|
2021
Q4 | $258K | Buy |
1,014
+465
| +85% | +$118K | 0.07% | 168 |
|
|
2021
Q3 | $211K | Buy |
+549
| New | +$211K | 0.05% | 180 |
|
|
2021
Q1 | – | Sell |
-6
| Closed | -$1K | – | 998 |
|
|
2020
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 1776 |
|